The Journal of Biochemistry
Online ISSN : 1756-2651
Print ISSN : 0021-924X
β-Hydroxyisovalerylshikonin Inhibits the Cell Growth of Various Cancer Cell Lines and Induces Apoptosis in Leukemia HL-60 Cells through a Mechanism Different from Those of Fas and Etoposide
Sachiko HashimotoMan XuYutaka MasudaToshihiro AiuchiShigeo NakajoJudong CaoMasazumi MiyakoshiYoshiteru IdaKazuyasu Nakaya
Author information
JOURNAL FREE ACCESS

1999 Volume 125 Issue 1 Pages 17-23

Details
Abstract

β-Hydroxyisovalerylshikonin (β-HIVS), which was isolated from the plant, Lithospermium radix, inhibited the growth of various lines of cancer cells derived from human solid, tumors at low concentrations between 10-8 and 10-6M. When HL-60 cells were treated with 10-6M β-HIVS for 3 h, characteristic features of apoptosis, such as DNA fragmentation, nuclear fragmentation, and activation of caspase-3-like activity, were observed. The most characteristic features of the effect of β-HIVS were the remarkable morphological changes induced upon treatment of HL-60 cells with β-HIVS, as visualized on the staining of actin filaments with phalloidin labeled with tetramethylrhodamine B isothiocyanate. Moreover, activation of MAP kinases, such as ERK2, JNK and p38, was detected after treatment with 10-6M β-HIVS preceding the appearance of the characteristics of apoptosis, and the features of the activation of these MAP kinases were quite different from those of Fas and anticancer drug-induced apoptosis. The activation of JNK by β-HIVS was not inhibited by inhibitors of caspases, suggesting that JNK is located either upstream or independent of the caspase signaling pathway. β-HIVS did not inhibit the activity of topoisomerase II. These results indicate that β-HIVS induces apoptosis in HL-60 cells through a mechanism unlike those reported for anti-Fas antibodies and etoposide.

Content from these authors
© The Japanese Biochemical Society
Previous article Next article
feedback
Top